Evidence map›Paper›PMID 33102250›Full record

ArticleFrontiers in cellular and infection microbiology2020

Melatonin Prevents Brain Damage and Neurocognitive Impairment Induced by

Brenda Jaqueline de Azevedo Ataide, Nayara Kauffmann, Nívia de Souza Franco Mendes, Marjorie Lujan Marques Torres, Larissa Medeiros Dos Anjos, Adelaide da Conceição Fonseca Passos, Suellen Alessandra Soares de Moraes, Evander de Jesus Oliveira Batista, Anderson Manoel Herculano, Karen Renata Herculano Matos Oliveira

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Experimental Granulomatous Amebic Encephalitis Caused byTropical medicine and infectious disease · 2024
    Article
  5. Review
  6. Review
  7. Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brenda Jaqueline de Azevedo AtaideLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Nayara KauffmannLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Nívia de Souza Franco MendesLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Marjorie Lujan Marques TorresLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Larissa Medeiros Dos AnjosLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Adelaide da Conceição Fonseca PassosLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Suellen Alessandra Soares de MoraesLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Evander de Jesus Oliveira BatistaLaboratory of Protozoology, Topical Medicine Nucleus, UFPa, Belém, Brazil.
Anderson Manoel HerculanoLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.
Karen Renata Herculano Matos OliveiraLaboratory of Experimental Neuropharmacology, Biological Science Institute, UFPa, Belém, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral malaria is characterized by permanent cognitive impairments in

Indexed as

Malaria, CerebralMelatoninAnimalsBrainDisease Models, AnimalMiceMice, Inbred C57BLPlasmodium bergheiMelatoninblood–brain barriercerebral malariamelatoninneurobehavioral impairmentPlasmodium

Identifiers

PMID33102250
PMCPMC7554304
OpenAlexW3090916714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.